Header

UZH-Logo

Maintenance Infos

Radiation dosimetry of [F]-PSS232-a PET radioligand for imaging mGlu5 receptors in humans


Sah, Bert-Ram; Sommerauer, Michael; Mu, Linjing; Gonzalez, Gloria Pla; Geistlich, Susanne; Treyer, Valerie; Schibli, Roger; Buck, Alfred; Warnock, Geoffrey; Ametamey, Simon M (2019). Radiation dosimetry of [F]-PSS232-a PET radioligand for imaging mGlu5 receptors in humans. EJNMMI Research, 9(1):56.

Abstract

PURPOSE

(E)-3-(pyridin-2-ylethynyl)cyclohex-2-enone O-(3-(2-[F]-fluoroethoxy)propyl) oxime ([F]-PSS232) is a new PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGlu5), and has shown promising results in rodents and humans. The aim of this study was to estimate the radiation dosimetry and biodistribution in humans, to assess dose-limiting organs, and to demonstrate safety and tolerability of [F]-PSS232 in healthy volunteers.

METHODS

PET/CT scans of six healthy male volunteers (mean age 23.5 ± 1.7; 21-26 years) were obtained after intravenous administration of 243 ± 3 MBq of [F]-PSS232. Serial whole-body (vertex to mid-thigh) PET scans were assessed at ten time points, up to 90 min after tracer injection. Calculation of tracer kinetics and cumulated organ activities were performed using PMOD 3.7 software. Dosimetry estimates were calculated using the OLINDA/EXM software.

RESULTS

Injection of [F]-PSS232 was safe and well tolerated. Organs with highest absorbed doses were the gallbladder wall (0.2295 mGy/MBq), liver (0.0547 mGy/MBq), and the small intestine (0.0643 mGy/MBq). Mean effective dose was 3.72 ± 0.12 mSv/volunteer (range 3.61-3.96 mSv; 0.0153 mSv/MBq).

CONCLUSION

[F]-PSS232, a novel [F]-labeled mGlu5 tracer, showed favorable dosimetry values. Additionally, the tracer was safe and well tolerated.

Abstract

PURPOSE

(E)-3-(pyridin-2-ylethynyl)cyclohex-2-enone O-(3-(2-[F]-fluoroethoxy)propyl) oxime ([F]-PSS232) is a new PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGlu5), and has shown promising results in rodents and humans. The aim of this study was to estimate the radiation dosimetry and biodistribution in humans, to assess dose-limiting organs, and to demonstrate safety and tolerability of [F]-PSS232 in healthy volunteers.

METHODS

PET/CT scans of six healthy male volunteers (mean age 23.5 ± 1.7; 21-26 years) were obtained after intravenous administration of 243 ± 3 MBq of [F]-PSS232. Serial whole-body (vertex to mid-thigh) PET scans were assessed at ten time points, up to 90 min after tracer injection. Calculation of tracer kinetics and cumulated organ activities were performed using PMOD 3.7 software. Dosimetry estimates were calculated using the OLINDA/EXM software.

RESULTS

Injection of [F]-PSS232 was safe and well tolerated. Organs with highest absorbed doses were the gallbladder wall (0.2295 mGy/MBq), liver (0.0547 mGy/MBq), and the small intestine (0.0643 mGy/MBq). Mean effective dose was 3.72 ± 0.12 mSv/volunteer (range 3.61-3.96 mSv; 0.0153 mSv/MBq).

CONCLUSION

[F]-PSS232, a novel [F]-labeled mGlu5 tracer, showed favorable dosimetry values. Additionally, the tracer was safe and well tolerated.

Statistics

Citations

Altmetrics

Downloads

20 downloads since deposited on 31 Jul 2019
20 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Nuclear Medicine
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:25 June 2019
Deposited On:31 Jul 2019 12:48
Last Modified:01 Oct 2019 11:38
Publisher:SpringerOpen
ISSN:2191-219X
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1186/s13550-019-0522-9
PubMed ID:31240594

Download

Gold Open Access

Download PDF  'Radiation dosimetry of [F]-PSS232-a PET radioligand for imaging mGlu5 receptors in humans'.
Preview
Content: Published Version
Filetype: PDF
Size: 671kB
View at publisher
Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)